The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype

Affiliations

• ¹ Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA cdschinke@uams.edu gjmorgan@uams.edu.
• ² Cancer Resarch and Biostatistics, Seattle, WA, USA.
• ³ Adaptive Biotechnologies, San Francisco, CA, USA.
• ⁴ Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
• ⁵ Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
• ⁶ Mt. Sinai School of Medicine, New York, NY, USA.